English: Overview of the use and applications of Convalescent plasma (CP) therapy. Virus-neutralizing antibodies in the plasma of a patient who recovered from COVID-19 can be administered prophylactically to prevent infection in vulnerable individuals and those with known exposure to the virus (Prophylaxis). Convalescent plasma can also be administered to infected individuals to improve the clinical outcome (Treatment). CP, convalescent plasma; COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Date
Source
Montelongo-Jauregui D, Vila T, Sultan AS, Jabra-Rizk MA (2020) Convalescent serum therapy for COVID-19: A 19th century remedy for a 21st century disease. PLoS Pathog 16(8): e1008735.
to share – to copy, distribute and transmit the work
to remix – to adapt the work
Under the following conditions:
attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
https://creativecommons.org/licenses/by/4.0CC BY 4.0 Creative Commons Attribution 4.0 truetrue
Captions
Overview of the use and applications of Convalescent plasma (CP) therapy.
Uploaded a work by Daniel Montelongo-Jauregui, Taissa Vila, Ahmed S. Sultan, and Mary Ann Jabra-Rizk from Montelongo-Jauregui D, Vila T, Sultan AS, Jabra-Rizk MA (2020) Convalescent serum therapy for COVID-19: A 19th century remedy for a 21st century disease. PLoS Pathog 16(8): e1008735. https://doi.org/10.1371/journal.ppat.1008735 with UploadWizard
File usage
The following pages on the English Wikipedia use this file (pages on other projects are not listed):